CYTOTOXIC ACTION OF SHIGA TOXIN IN TRIPLE-NEGATIVE BREAST CANCER: POTENTIAL THERAPEUTIC USE AND INVOLVEMENT OF TDP-43
Evaluation of Histamine H3 and H4 Receptors as Prognostic Biomarkers in Triple-Negative Breast Cancer
The displacement of translesion DNA synthesis polymerases from the replisome sensitize tumor cells to genotoxins
Lapatinib treatment induces cytotoxic effects on different tumor cell lines and decreases Stemness in triple-negative breast cancer cell lines.
Anticancer activity of novel copper (II) compounds with an acylhydrazone ligands against 2D and 3D human breast cancer models.
Transcriptional factor STAT3 as a potential target for nanoparticle-delivered therapeutics, towards CD44+ breast cancer cells
